mei: +15%

NRT holds 95.2% of the MEI subsidiary.

This rose 15% possibly due to :

http://stocknessmonster.com/news-item?S=NRT&E=ASX&N=298408

Extract:

" (WASHINGTON, DC June 17, 2003) Marshall Edwards Inc, subsidiary of Novogen Limited (NASDAQ: NVGN) announced today that an Investigational New Drug application (IND) has been cleared by the US
Food and Drug Administration (FDA) for the start of a phase II clinical trial of phenoxodiol, administered orally, to women with squamous cell carcinoma (SCC) of the cervix, vagina and vulva".

+++++++++++++++++++++++++++++++++++

That is good news.

Gerry